D.E. Shaw & Co
FMTX

D.E. Shaw & Co’s Forma Therapeutics Holdings, Inc. Common Stock FMTX Stock Holding History

D.E. Shaw & Co’s Portfolio FMTX Stock Details FMTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-16,010
Closed -$319K – 5568
2022
Q3 		$319K Sell
16,010
-66,485
-81% -$877K ﹤0.01% 4268
2022
Q2 		$568K Buy
82,495
+69,183
+520% +$486K ﹤0.01% 4020
2022
Q1 		$124K Buy
+13,312
New +$142K ﹤0.01% 4966

D.E. Shaw & Co's FMTX Position: Q4 2022 in Review

D.E. Shaw & Co sold out of Forma Therapeutics Holdings, Inc. Common Stock (FMTX) in Q4 2022, closing a stake of 16,010 shares — an estimated $319K sold.

D.E. Shaw & Co first reported a position in FMTX in Q1 2022 and held it in 3 quarters. The position peaked at $568K in Q2 2022. 0 funds tracked by Wall St. Rank hold FMTX as of Q4 2022.

  • D.E. Shaw & Co reported no remaining Forma Therapeutics Holdings, Inc. Common Stock position as of Q4 2022 after selling out during the quarter.
  • D.E. Shaw & Co sold 16,010 Forma Therapeutics Holdings, Inc. Common Stock shares in Q4 2022, an estimated $319K.
  • D.E. Shaw & Co first reported a position in Forma Therapeutics Holdings, Inc. Common Stock in Q1 2022 and held it in 3 quarters.
  • D.E. Shaw & Co's Forma Therapeutics Holdings, Inc. Common Stock position peaked at $568K in Q2 2022.
  • 0 funds tracked by Wall St. Rank held Forma Therapeutics Holdings, Inc. Common Stock as of Q4 2022.

Based on D.E. Shaw & Co's 13F filing for Q4 2022, filed 14 Feb 2023.